Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07172347 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

StatusRecruiting
PhasePhase 2
Started2025-10-31
View on ClinicalTrials.gov ↗

Amendment history

2025-12-29
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-10-20→confirmed 2025-10-31
Study sitesdetails revised at 1 of 1 site
2025-09-08
minor
Original filing
This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study
Trial Details
NCT Number NCT07172347
Lead Sponsor Jiangsu vcare pharmaceutical technology co., LTD
Conditions Non-segmental Vitiligo
Enrollment 120 participants
Start Date 2025-10-31
Primary Completion 2027-08-30 (estimated)
Study Completion 2027-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-02